Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive system, blood system, nervous system, parenteral nutrition, antibiotics, first aid, anesthetics, and tumor; and tablets, capsules, granules, and ointments in the fields of cardiovascular, anti-infection, digestive system, CNS system, diabetes, and hepatic diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.
Haisco Pharmaceutical Dividend Announcement
• Haisco Pharmaceutical announced a semi annually dividend of ¥0.14 per ordinary share which will be made payable on 2024-09-18. Ex dividend date: 2024-09-18
• Haisco Pharmaceutical annual dividend for 2024 was ¥0.34
• Haisco Pharmaceutical's trailing twelve-month (TTM) dividend yield is 0.99%
• Haisco Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 88.72%
Haisco Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-09-18 | ¥0.14 | semi annually | 2024-09-18 |
2024-05-24 | ¥0.20 | semi annually | 2024-05-24 |
2022-07-05 | ¥0.19 | semi annually | 2022-07-05 |
2021-04-28 | ¥0.37 | semi annually | 2021-04-28 |
2020-07-03 | ¥0.09 | semi annually | 2020-07-03 |
2019-05-15 | ¥0.19 | semi annually | 2019-05-15 |
2018-07-02 | ¥0.28 | semi annually | 2018-07-02 |
2017-06-09 | ¥0.46 | semi annually | 2017-06-09 |
2016-04-26 | ¥0.25 | semi annually | |
2015-05-27 | ¥0.20 | semi annually | |
2014-05-19 | ¥0.25 | semi annually | |
2013-03-11 | ¥0.75 | semi annually | |
2012-03-08 | ¥0.60 | semi annually |
Haisco Pharmaceutical Dividend per year
Haisco Pharmaceutical Dividend growth
Haisco Pharmaceutical Dividend Yield
Haisco Pharmaceutical current trailing twelve-month (TTM) dividend yield is 0.99%. Interested in purchasing Haisco Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Haisco Pharmaceutical Financial Ratios
Haisco Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Haisco Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Haisco Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Haisco Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Haisco Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Haisco Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Haisco Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Haisco Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Haisco Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Haisco Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Haisco Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Haisco Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.